Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Analyst Ratings for TransMedics Group

Over the past 3 months, 4 analysts have published their opinion on TransMedics Group (NASDAQ:TMDX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

TMDX

Read More

Earnings Outlook For TransMedics Group

TransMedics Group (NASDAQ:TMDX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that TransMedics Group will report an earnings per share (EPS) of $-0.38.

TMDX